Arginine effect on height growth of children

Evaluation of the effect of arginine administration on height growth of Children in lower limit range

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

IRCT

Registry ID

IRCT20230603058376N1

Enrollment

Registered

2023-10-07

Start date

2023-10-11

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Short stature. Short stature (child)

Interventions

Intervention group: Vitamin D 1000 IU daily + Argenine 250mg daily.

Eligibility

Sex/Gender

All

Age

5 Years to 15 Years

Inclusion criteria

Inclusion criteria: Children in pre-pubertal ages Absence of any underlying diseases Not below the lower normal height limit No indications for growth hormone prescription

Exclusion criteria

Exclusion criteria: Having reached sexual maturity Presence of underlying diseases such as diabetes, hypothyroidism, or kidney diseases Height below the lower normal limit Past or current use of growth hormone Sensitivity or adverse reactions to Vitamin D or Arginine

Design outcomes

Primary

Measure	Time frame
Height of a child. Timepoint: 12 months with 3 month interval. Method of measurement: Height measuring device.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSimin zare

Ardabil University of Medical Sciences

info@arums.ac.ir+98 45 3353 4790

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026